Lois Peltz, Co-Chair of the British Technion Society (BTS), has been awarded an honorary doctorate from the Technion, joining an elite group of individuals which include Albert Einstein and Margaret Thatcher. The award will be received in a special ceremony at the Technion in Haifa on June 5th.
Lois was appointed Co-Chair of the British Technion Society in 2000 and this prestigious award is a tribute to her enormous efforts and incredible achievements on behalf of the Technion in the UK. Working closely with BTS’ supporters and donors, Lois has successfully raised funds to provide new physical facilities on campus including an outdoor swimming pool and student dormitories as well as graduate scholarship schemes. To keep the name of the Technion student Ron Arad alive, Lois also created the UK’s Ron Arad Lecture Series in 2002, the most recent being delivered by Nobel Laureate Professor Aaron Ciechanover.
During her time as Chairman, Lois has placed major importance in developing initiatives to communicate the Technion’s science to young people at schools and universities to help nurture a stronger connection with the Technion and the State of Israel. She successfully secured £1 million for a student exchange programme which has enabled students from British universities to study at the Technion, and she also created the ‘Young Scientist Lecture Series’ which has seen the Technion’s leading Professors visit British schools to give science lessons.
On awarding Lois with a doctorate, Professor Peretz Lavie, Vice-President of the Technion commented: "Lois's energy and leadership have played a major role in turning the British Technion Society into a vibrant and successful organisation".
With the news of her achievement, Lois Peltz commented: “I feel incredibly honoured to have been chosen for such a prestigious award. I am very lucky in that I work for an amazing institution which continues to deliver incredible results which are helping to change people’s lives around the world. From drugs to treat Parkinson’s disease to proteins which can cure certain cancers, the Technion has proved time and again to be the leading university in its field. I want to make sure that as many people as possible in the UK, whether medics, students or the general public, can benefit from the Technion’s expertise.
“I am immensely grateful to all of BTS’ supporters without whom, so many of our programmes would not be possible.” |